Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction

J Mascherbauer; E Grunig; M Halank; W Hohenforst-Schmidt; AA Kammerlander; Ingrid Pretsch; R Steringer-Mascherbauer; S Ulrich; IM Lang; M Wargenau; R Frey; D Bonderman

doi:10.1007/s00508-016-1068-8

Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction

J Mascherbauer, E Grunig, M Halank, W Hohenforst-Schmidt, AA Kammerlander, Ingrid Pretsch (Co-Autor/-in), R Steringer-Mascherbauer, S Ulrich, IM Lang, M Wargenau, R Frey, D Bonderman

Universitätsklinik für Innere Medizin 2 - Kardiologie, Internistische Intensivmedizin und Notaufnahme

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

18 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	882-889
Fachzeitschrift	WIENER KLINISCHE WOCHENSCHRIFT
Jahrgang	128
Ausgabenummer	23-24
DOIs	https://doi.org/10.1007/s00508-016-1068-8
Publikationsstatus	Veröffentlicht - 2016

Zugriff auf Dokument

10.1007/s00508-016-1068-8

Dieses zitieren

Mascherbauer, J., Grunig, E., Halank, M., Hohenforst-Schmidt, W., Kammerlander, AA., Pretsch, I., Steringer-Mascherbauer, R., Ulrich, S., Lang, IM., Wargenau, M., Frey, R., & Bonderman, D. (2016). Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction. WIENER KLINISCHE WOCHENSCHRIFT, 128(23-24), 882-889. https://doi.org/10.1007/s00508-016-1068-8

@article{6d15204558d24f2b989d6ce728446767,

title = "Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction",

keywords = "SOLUBLE GUANYLATE-CYCLASE, PHOSPHODIESTERASE-5 INHIBITION, EUROPEAN-SOCIETY, DYSFUNCTION, GUIDELINES, RATIONALE, DIAGNOSIS, DESIGN, TRIAL, LEPHT",

author = "J Mascherbauer and E Grunig and M Halank and W Hohenforst-Schmidt and AA Kammerlander and Ingrid Pretsch and R Steringer-Mascherbauer and S Ulrich and IM Lang and M Wargenau and R Frey and D Bonderman",

note = "Pretsch: Paracelsus Medial Univ Salzburg, Dept Cardiol, Salzburg, Austria",

year = "2016",

doi = "10.1007/s00508-016-1068-8",

language = "English",

volume = "128",

pages = "882--889",

journal = "WIENER KLINISCHE WOCHENSCHRIFT",

issn = "0043-5325",

publisher = "Springer Nature",

number = "23-24",

}

Mascherbauer, J, Grunig, E, Halank, M, Hohenforst-Schmidt, W, Kammerlander, AA, Pretsch, I, Steringer-Mascherbauer, R, Ulrich, S, Lang, IM, Wargenau, M, Frey, R & Bonderman, D 2016, 'Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction', WIENER KLINISCHE WOCHENSCHRIFT, Jg. 128, Nr. 23-24, S. 882-889. https://doi.org/10.1007/s00508-016-1068-8

TY - JOUR

T1 - Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction

AU - Mascherbauer, J

AU - Grunig, E

AU - Halank, M

AU - Hohenforst-Schmidt, W

AU - Kammerlander, AA

AU - Pretsch, Ingrid

AU - Steringer-Mascherbauer, R

AU - Ulrich, S

AU - Lang, IM

AU - Wargenau, M

AU - Frey, R

AU - Bonderman, D

N1 - Pretsch: Paracelsus Medial Univ Salzburg, Dept Cardiol, Salzburg, Austria

PY - 2016

Y1 - 2016

KW - SOLUBLE GUANYLATE-CYCLASE

KW - PHOSPHODIESTERASE-5 INHIBITION

KW - EUROPEAN-SOCIETY

KW - DYSFUNCTION

KW - GUIDELINES

KW - RATIONALE

KW - DIAGNOSIS

KW - DESIGN

KW - TRIAL

KW - LEPHT

U2 - 10.1007/s00508-016-1068-8

DO - 10.1007/s00508-016-1068-8

M3 - Original Article

SN - 0043-5325

VL - 128

SP - 882

EP - 889

JO - WIENER KLINISCHE WOCHENSCHRIFT

JF - WIENER KLINISCHE WOCHENSCHRIFT

IS - 23-24

ER -